» Articles » PMID: 25018920

Section 4: Contrast-induced AKI

Overview
Publisher Elsevier
Specialty Nephrology
Date 2014 Jul 15
PMID 25018920
Citations 19
Affiliations
Soon will be listed here.
Citing Articles

Lymphocyte to c-reactive protein ratio predicts the risk of contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention.

Xiang L, Qiu B, Chen L, Wang C, Zhang W, Liu L BMC Cardiovasc Disord. 2025; 25(1):140.

PMID: 40021983 PMC: 11869660. DOI: 10.1186/s12872-025-04522-0.


Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury prevention.

Theofilis P, Kalaitzidis R World J Radiol. 2024; 16(6):168-183.

PMID: 38983842 PMC: 11229940. DOI: 10.4329/wjr.v16.i6.168.


The association between systemic inflammatory response index and contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.

Chen J, Zhang L, Liang W, Lin W, Chen X, Lin Z Ren Fail. 2024; 46(1):2330621.

PMID: 38561250 PMC: 10986433. DOI: 10.1080/0886022X.2024.2330621.


A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.

Qiu H, Zhu Y, Shen G, Wang Z, Li W Clin Interv Aging. 2023; 18:453-465.

PMID: 36987461 PMC: 10040169. DOI: 10.2147/CIA.S402408.


A novel risk factor of contrast associated acute kidney injury in patients after enhanced computed tomography: a retrospective study.

Li Y, Shi Y, Deng W, Xiao S, Hu W, Huang C PeerJ. 2022; 10:e14224.

PMID: 36285330 PMC: 9588300. DOI: 10.7717/peerj.14224.


References
1.
Streetman D, Nafziger A, Destache C, Bertino Jr A . Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy. 2001; 21(4):443-51. DOI: 10.1592/phco.21.5.443.34490. View

2.
Cannella C, Wilkinson S . Acute renal failure associated with inhaled tobramycin. Am J Health Syst Pharm. 2006; 63(19):1858-61. DOI: 10.2146/ajhp060196. View

3.
Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D . The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007; 49(12):1283-8. DOI: 10.1016/j.jacc.2006.11.034. View

4.
Swan S, Lambrecht L, Townsend R, Davies B, McCloud S, Parker J . Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol. 1999; 34(7):443-8. DOI: 10.1097/00004424-199907000-00001. View

5.
Briguori C, Colombo A, Airoldi F, Melzi G, Michev I, Carlino M . Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv. 2006; 67(2):175-80. DOI: 10.1002/ccd.20592. View